Heart injury signs are associated with higher and earlier mortality in coronavirus disease 2019 (COVID-19)
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
Importance
Heart injury can be easily induced by viral infection such as adenovirus and enterovirus. However, whether coronavirus disease 2019 (COVID-19) causes heart injury and hereby impacts mortality has not yet been fully evaluated.
Objective
To explore whether heart injury occurs in COVID-19 on admission and hereby aggravates mortality later.
Design, Setting, and Participants
A single-center retrospective cohort study including 188 COVID-19 patients admitted from December 25, 2019 to January 27, 2020 in Wuhan Jinyintan Hospital, China; follow up was completed on February 11, 2020.
Exposures
High levels of heart injury indicators on admission (hs-TNI; CK; CK-MB; LDH; α-HBDH).
Main Outcomes and Measures
Mortality in hospital and days from admission to mortality (survival days).
Results
Of 188 patients with COVID-19, the mean age was 51.9 years (standard deviation: 14.26; range: 21∼83 years) and 119 (63.3%) were male. Increased hs-TnI levels on admission tended to occur in older patients and patients with comorbidity (especially hypertension). High hs-TnI on admission (≥ 6.126 pg/mL), even within the clinical normal range (0∼28 pg/mL), already can be associated with higher mortality. High hs-TnI was associated with increased inflammatory levels (neutrophils, IL-6, CRP, and PCT) and decreased immune levels (lymphocytes, monocytes, and CD4 + and CD8 + T cells). CK was not associated with mortality. Increased CK-MB levels tended to occur in male patients and patients with current smoking. High CK-MB on admission was associated with higher mortality. High CK-MB was associated with increased inflammatory levels and decreased lymphocytes. Increased LDH and α-HBDH levels tended to occur in older patients and patients with hypertension. Both high LDH and α-HBDH on admission were associated with higher mortality. Both high LDH and α-HBDH were associated with increased inflammatory levels and decreased immune levels. hs-TNI level on admission was negatively correlated with survival days ( r = -0.42, 95% CI= -0.64∼-0.12, P=0.005). LDH level on admission was negatively correlated with survival days ( r = -0.35, 95% CI= -0.59∼-0.05, P=0.022).
Conclusions and Relevance
Heart injury signs arise in COVID-19, especially in older patients, patients with hypertension and male patients with current smoking. COVID-19 virus might attack heart via inducing inflammatory storm. High levels of heart injury indicators on admission are associated with higher mortality and shorter survival days. COVID-19 patients with signs of heart injury on admission must be early identified and carefully managed by cardiologists, because COVID-19 is never just confined to respiratory injury.
Key points
Question
Does coronavirus disease 2019 (COVID-19) cause heart injury and hereby impact mortality?
Findings
In this retrospective cohort study including 188 patients with COVID-19, patients with high levels of high-sensitivity cardiac troponin I (hs-TNI) on admission had significantly higher mortality (50.0%) than patients with moderate or low levels of hs-TNI (10.0% or 9.1%). hs-TNI level on admission was significantly negatively correlated with survival days ( r = -0.42, 95% CI= -0.64∼-0.12, P=0.005).
Meaning
COVID-19 patients with signs of heart injury on admission must be early identified and carefully managed by cardiologists, in order to maximally prevent or rescue heart injury-related mortality in COVID-19.
Article activity feed
-
SciScore for 10.1101/2020.02.26.20028589: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement Consent: Written informed consent was waived because this research was retrospective observation and deindividuation. Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Table 2: Resources
Software and Algorithms Sentences Resources Statistical analysis: SPSS for Windows (Version 24.0, IBM) and Graphpad prism 7.0 software were used for statistical analysis. SPSSsuggested: (SPSS, RRID:SCR_002865)Graphpadsuggested: (GraphPad, RRID:SCR_000306)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Result…SciScore for 10.1101/2020.02.26.20028589: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement Consent: Written informed consent was waived because this research was retrospective observation and deindividuation. Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Table 2: Resources
Software and Algorithms Sentences Resources Statistical analysis: SPSS for Windows (Version 24.0, IBM) and Graphpad prism 7.0 software were used for statistical analysis. SPSSsuggested: (SPSS, RRID:SCR_002865)Graphpadsuggested: (GraphPad, RRID:SCR_000306)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: We detected the following sentences addressing limitations in the study:Some limitations existed in this study. First, we only assessed heart injury from the perspective of serum myocardial enzymes and protein. It would be better if echocardiography and electrocardiograph were also measured in this study. Secondly, it would be better if we could assess heart injury-specific mortality in the future study with a larger sample size. Thirdly, we have not been able to obtain myocardial tissues from COVID-19 patients. Thus we currently cannot directly observe myocardial injury from the golden standard of pathology. Although the first autopsy of COVID-19 patient was completed and pulmonary pathology was obtained on Feb 16, 2020 in Wuhan Jinyintan Hospital (China), it remains a long way to remind clinicians to focus on cardiac pathology for COVID-19 infection. Our present results also can remind pathologists to pay attention to cardiac pathology in the future, especially for those deceased COVID-19 patients who had high heart injury indicators on admission.
Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
-